We are live on
!
Find out more
ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
1-Year Est. Return
7.38%
This Fund
S&P 500
This Quarter
Est. Return
+4.73%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$270M
AUM Growth
-$29.4M
(-9.8%)
Cap. Flow
-$45.9M
Cap. Flow
% of AUM
-17.01%
Top 10 Holdings %
Top 10 Hldgs %
39.46%
Holding
110
New
22
Increased
25
Reduced
44
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMSG
Amsurg Corp
AMSG
|
+$10.3M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$3.67M |
| 3 |
AKRX
Akorn Inc
AKRX
|
+$3.38M |
| 4 |
SHPG
Shire pic
SHPG
|
+$3.35M |
| 5 |
HCA Healthcare
HCA
|
+$3.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WMGI
Wright Medical Group Inc
WMGI
|
+$8.81M |
| 2 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$8.25M |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$5.07M |
| 4 |
Encompass Health
EHC
|
+$5.04M |
| 5 |
Becton Dickinson
BDX
|
+$4.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 87.33% |
| 2 | Financials | 3.58% |
| 3 | Industrials | 1.13% |
| 4 | Energy | 0.58% |
| 5 | Technology | 0.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALR
51
DELISTED
AlerisLife Inc
ALR
| $1.1M | 0.41% |
57,508
+8,299
| +17% | +$177K |
|
52
Brookdale Senior Living
BKD
$3.49B
| $1.03M | 0.38% |
59,070
-68,050
| -54% | -$1.17M |
|
53
Elevance Health
ELV
$81.5B
| $981K | 0.36% |
7,829
-17,325
| -69% | -$2.24M |
|
|
GI
54
DELISTED
EndoChoice Holdings, Inc.
GI
| $971K | 0.36% |
121,663
-47,500
| -28% | -$222K |
|
|
DERM
55
DELISTED
Dermira, Inc.
DERM
| $886K | 0.33% |
26,188
| – | – |
|
56
Universal Health Services
UHS
$10.2B
| $820K | 0.3% |
6,657
-37,250
| -85% | -$4.72M |
|
|
MDCO
57
DELISTED
Medicines Co
MDCO
| $777K | 0.29% |
+20,600
| New | +$776K |
|
|
CSLT
58
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $769K | 0.29% |
184,826
+107,268
| +138% | +$438K |
|
59
Tandem Diabetes Care
TNDM
$1.34B
| $726K | 0.27% |
9,481
-13,586
| -59% | -$991K |
|
60
VanEck Biotech ETF
BBH
$400M
| $709K | 0.26% |
6,150
-10,150
| -62% | -$1.16M |
|
61
Cardinal Health
CAH
$53.9B
| $707K | 0.26% |
+9,100
| New | +$735K |
|
|
PRXL
62
DELISTED
Parexel International Corp
PRXL
| $701K | 0.26% |
+10,100
| New | +$682K |
|
63
Steris
STE
$22.3B
| $694K | 0.26% |
9,500
-24,200
| -72% | -$1.71M |
|
|
ALPN
64
DELISTED
Alpine Immune Sciences Inc
ALPN
| $694K | 0.26% |
21,353
+4,907
| +30% | +$119K |
|
65
Exelixis
EXEL
$13.3B
| $643K | 0.24% |
+50,300
| New | +$544K |
|
|
ALDR
66
DELISTED
Alder Biopharmaceuticals
ALDR
| $639K | 0.24% |
19,500
+9,700
| +99% | +$295K |
|
|
PARN
67
DELISTED
Parnell Pharmaceuticals Holdings Ltd
PARN
| $637K | 0.24% |
448,802
| – | – |
|
68
Illumina
ILMN
$31B
| $630K | 0.23% |
3,567
-411
| -10% | -$65.8K |
|
69
Neurocrine Biosciences
NBIX
$16.8B
| $618K | 0.23% |
12,200
-1,900
| -13% | -$94.6K |
|
|
KERX
70
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $616K | 0.23% |
+116,000
| New | +$625K |
|
71
Bausch Health
BHC
$2.58B
| $550K | 0.2% |
22,400
-17,700
| -44% | -$458K |
|
72
Penumbra
PEN
$12.7B
| $547K | 0.2% |
7,200
-9,700
| -57% | -$669K |
|
|
KITE
73
DELISTED
Kite Pharma, Inc.
KITE
| $547K | 0.2% |
+9,800
| New | +$546K |
|
|
HZNP
74
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $472K | 0.17% |
26,040
-30,400
| -54% | -$594K |
|
75
Incyte
INCY
$24.2B
| $471K | 0.17% |
5,000
-3,300
| -40% | -$278K |
|
Similar funds
VAFP
CA
SCM
FWM
TOPU
CCMU
TGI
HSCU
Endurant Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Endurant Capital Management held 110 positions worth $270M, down 9.8% from $299M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Endurant Capital Management withdrew a net $45.9M in Q3 2016, closing 14 positions and reducing 44 holdings. Its most notable exit was Standard BioTools, an estimated $2.32M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 87% of assets, down from 89% a quarter earlier, followed by Financials and Industrials.
Against the trend, Endurant Capital Management opened a new position in Amsurg Corp worth $9.89M.
- Endurant Capital Management's largest Q3 2016 buy was Amsurg Corp: 147,500 shares worth $9.89M.
- Endurant Capital Management added most to Express Scripts Holding Company in Q3 2016, an estimated $3.67M increase.
- Endurant Capital Management's biggest Q3 2016 reduction was Wright Medical Group Inc, cutting an estimated $8.81M.
- Endurant Capital Management fully exited Standard BioTools in Q3 2016, selling an estimated $2.32M.
- Endurant Capital Management's ten largest holdings make up 39% of its $270M portfolio in Q3 2016.
- Endurant Capital Management opened 22 new positions and closed 14 in Q3 2016.
- Endurant Capital Management's portfolio value fell 9.8% quarter-over-quarter to $270M.
Based on Endurant Capital Management's 13F filing for Q3 2016, filed 15 Nov 2016.